Skip to main content

2.

Baseline CTC comparison according to clinical characteristics in first-line TNBC (N=50)

Characteristics Number of patients n (%) P
≤2 CTC/2 mL >2 CTC/2 mL
Age at diagnosis (year) 0.754a
 ≤45 17 9 (52.9) 8 (47.1)
 >45 33 19 (57.6) 14 (42.4)
 Unknown 0
Histological type 0.497a
 Ductal 48 26 (54.2) 22 (45.8)
 Lobular 0 0 (NA) 0 (NA)
 Others 2 2 (100) 0 (0)
 Unknown 0
Tumor grade 1.000b
 I 1 1 (100) 0 (0)
 II 20 9 (45.0) 11 (55.0)
 III 15 8 (53.3) 7 (46.7)
 Unknown 14
Tumor stage 0.247b
 I 3 2 (66.7) 1 (33.3)
 II 17 7 (41.2) 10 (58.8)
 III 23 15 (65.2) 8 (34.8)
 IV 1 1 (100) 0 (0)
 Unknown 6
Bone metastasis at relapse 0.709a
 Yes 15 9 (60.0) 6 (40.0)
 No 35 19 (54.3) 16 (45.7)
 Unknown 0
Liver metastasis at relapse 0.815a
 Yes 11 7 (63.6) 4 (36.4)
 No 39 21 (53.8) 18 (46.2)
 Unknown 0
Lung metastasis at relapse 0.034a
 Yes 17 6 (35.3) 11 (64.7)
Table 2 (continued)